137 related articles for article (PubMed ID: 38628295)
1. SARS-CoV2 infections in heart transplant recipients: Vaccines still are our greatest weapon.
Tedeschi A; Gentile P; Palazzini M; Masciocco G; Leidi F; Monticelli M; Ammirati E; Garascia A
Int J Cardiol Heart Vasc; 2024 Apr; 51():101379. PubMed ID: 38628295
[No Abstract] [Full Text] [Related]
2. Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant Recipients.
Ali H; Ngo D; Aribi A; Arslan S; Dadwal S; Marcucci G; Nakamura R; Forman SJ; Chen J; Al Malki MM
Transplant Cell Ther; 2021 Nov; 27(11):938.e1-938.e6. PubMed ID: 34274492
[TBL] [Abstract][Full Text] [Related]
3. Impact of a booster dose on SARS-CoV2 mRNA vaccine-specific humoral-, B- and T cell immunity in pediatric stem cell transplant recipients.
Thole LML; Tóth L; Proß V; Siegle J; Stahl C; Hermsdorf G; Knabe A; Winkler A; Schrezenmeier E; Ludwig C; Eckert C; Eggert A; Schrezenmeier H; Sattler A; Schulte JH; Kotsch K
Front Immunol; 2023; 14():1239519. PubMed ID: 37942315
[TBL] [Abstract][Full Text] [Related]
4. Coordinated cellular and humoral immune responses after two-dose SARS-CoV2 mRNA vaccination in liver transplant recipients.
D'Offizi G; Agrati C; Visco-Comandini U; Castilletti C; Puro V; Piccolo P; Montalbano M; Meschi S; Tartaglia E; Sorace C; Leone S; Lapa D; Grassi G; Goletti D; Ippolito G; Vaia F; Ettorre GM; Lionetti R
Liver Int; 2022 Jan; 42(1):180-186. PubMed ID: 34719107
[TBL] [Abstract][Full Text] [Related]
5. Immunity After Vaccination Against SARS-CoV-2 in Lung Transplant?
López GMS; Moralejo RA; Roncal MP; Ortiz MTT; Loaiza CAQ; Rivilla AP; Gafas AP
Transplant Proc; 2022 Nov; 54(9):2479-2481. PubMed ID: 36257877
[TBL] [Abstract][Full Text] [Related]
6. Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients.
Biagio P; Rosa C; Nicola SM; Fabrizio S; Amerigo P; Giulia Z; Riccardo S; Riccardo V; Paolo R; Lorenzo S; Ivan G; Federico Ii Covid Team
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146758
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 in Heart Transplant Recipients: A Multicenter Analysis of the Northern Italian Outbreak.
Bottio T; Bagozzi L; Fiocco A; Nadali M; Caraffa R; Bifulco O; Ponzoni M; Lombardi CM; Metra M; Russo CF; Frigerio M; Masciocco G; Potena L; Loforte A; Pacini D; Faggian G; Onorati F; Sponga S; Livi U; Iacovoni A; Terzi A; Senni M; Rinaldi M; Boffini M; Marro M; Jorgji V; Carrozzini M; Gerosa G
JACC Heart Fail; 2021 Jan; 9(1):52-61. PubMed ID: 33309578
[TBL] [Abstract][Full Text] [Related]
8. Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipients.
McCune TR; Bray RA; Baran DA; Toepp AJ; Forte SJ; Gilgannon LT; Williams T; Chen S; Sadr H; Gebel HM; Herre JM
Transpl Immunol; 2022 Dec; 75():101722. PubMed ID: 36152939
[TBL] [Abstract][Full Text] [Related]
9. Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination.
Chiang TP; Alejo JL; Mitchell J; Kim JD; Abedon AT; Karaba AH; Thomas L; Levan ML; Garonzik-Wang JM; Avery RK; Pekosz A; Clarke WA; Warren DS; Tobian AAR; Massie AB; Segev DL; Werbel WA
Am J Transplant; 2022 Sep; 22(9):2254-2260. PubMed ID: 35429211
[TBL] [Abstract][Full Text] [Related]
10. The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective study.
Ngo D; Chen J; Tinajero J; Aribi A; Arslan S; Marcucci G; Nakamura R; Al Malki MM; Forman SJ; Dadwal S; Ali H
Stem Cell Res Ther; 2023 Apr; 14(1):95. PubMed ID: 37072867
[TBL] [Abstract][Full Text] [Related]
11. A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia.
Alberici F; Delbarba E; Manenti C; Econimo L; Valerio F; Pola A; Maffei C; Possenti S; Zambetti N; Moscato M; Venturini M; Affatato S; Gaggiotti M; Bossini N; Scolari F
Kidney Int; 2020 Jun; 97(6):1083-1088. PubMed ID: 32354634
[TBL] [Abstract][Full Text] [Related]
12. Comparative Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Against the Delta Variant.
Risk M; Shen C; Hayek SS; Holevinski L; Schiopu E; Freed G; Akin C; Zhao L
Clin Infect Dis; 2022 Aug; 75(1):e623-e629. PubMed ID: 35137006
[TBL] [Abstract][Full Text] [Related]
13. Third dose of SARS-CoV2 mRNA vaccination produces robust persistent cellular and humoral immune responses in liver transplant recipients.
Montalbano M; Piccolo P; Lionetti R; Visco-Comandini U; Agrati C; Grassi G; Meschi S; Matusali G; Conte F; Angelone F; Ettorre GM; Guglielmo N; Maggi F; Francalancia M; Mereu T; Puro V; Girardi E; D'Offizi G
Liver Int; 2023 May; 43(5):1120-1125. PubMed ID: 36929682
[TBL] [Abstract][Full Text] [Related]
14. Kidney transplant recipients' attitudes toward COVID-19 vaccination and barriers and enablers to vaccine acceptance.
Tharmaraj D; Dendle C; Polkinghorne KR; Mulley WR
Transpl Infect Dis; 2022 Feb; 24(1):e13749. PubMed ID: 34694682
[TBL] [Abstract][Full Text] [Related]
15. Humoral response to SARS-CoV-2 adenovirus vector vaccination (ChAdOx1 nCoV-19 [AZD1222]) in heart transplant recipients aged 18 to 70 years of age.
Tanner R; Starr N; Chan G; Dempsey E; Heffernan E; Newman E; O'Neill J; Hannan MM; Lynch B; Joyce E
J Heart Lung Transplant; 2022 Apr; 41(4):492-500. PubMed ID: 35090809
[TBL] [Abstract][Full Text] [Related]
16. Human endogenous retrovirus-enveloped baculoviral DNA vaccines against MERS-CoV and SARS-CoV2.
Cho H; Jang Y; Park KH; Choi H; Nowakowska A; Lee HJ; Kim M; Kang MH; Kim JH; Shin HY; Oh YK; Kim YB
NPJ Vaccines; 2021 Mar; 6(1):37. PubMed ID: 33741992
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of Ad26.COV2.S prime and two subsequent doses of mRNA SARS-CoV-2 vaccines in solid organ transplant recipients: A case series.
Chang A; Mitchell J; Alejo JL; Chiang TPY; Abedon AT; Kim JD; Avery RK; Tobian AAR; Levan ML; Warren DS; Garonzik-Wang JM; Massie AB; Segev DL; Werbel WA
Clin Transplant; 2022 Sep; 36(9):e14772. PubMed ID: 35822545
[No Abstract] [Full Text] [Related]
18. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial.
Hardt K; Vandebosch A; Sadoff J; Le Gars M; Truyers C; Lowson D; Van Dromme I; Vingerhoets J; Kamphuis T; Scheper G; Ruiz-Guiñazú J; Faust SN; Spinner CD; Schuitemaker H; Van Hoof J; Douoguih M; Struyf F;
Lancet Infect Dis; 2022 Dec; 22(12):1703-1715. PubMed ID: 36113538
[TBL] [Abstract][Full Text] [Related]
19. Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy.
Infante MS; Nemirovsky D; Devlin S; DeWolf S; Tamari R; Dahi PB; Lee YJ; Chung DJ; Politikos I; Barker J; Giralt SA; Babady NE; Ramanathan L; Papanicolaou GA; Seo S; Kamboj M; Perales MA; Shah GL
Transplant Cell Ther; 2024 Jan; 30(1):116.e1-116.e12. PubMed ID: 37806446
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 vaccine antibody response and breakthrough infections in transplant recipients.
Vanlerberghe B; Vrij C; Bogaerts K; Vermeersch P; Lagrou K; Molenberghs G; Rega F; Ceulemans LJ; van Raemdonck D; Jochmans I; Monbaliu D; Pirenne J; Vanuytsel T; Gillard P; Schoemans H; Cleemput JV; Kuypers D; Vos R; Nevens F; Verbeek J
J Med Virol; 2023 Apr; 95(4):e28736. PubMed ID: 37185854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
